questionsmedicales.fr
Organisations et économie des soins de santé
Contrôle social formel
Jurisprudence
Capacité mentale
Capacité mentale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Capacité mentale : Questions médicales les plus fréquentes",
"headline": "Capacité mentale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Capacité mentale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-27",
"dateModified": "2025-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Capacité mentale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Jurisprudence",
"url": "https://questionsmedicales.fr/mesh/D007603",
"about": {
"@type": "MedicalCondition",
"name": "Jurisprudence",
"code": {
"@type": "MedicalCode",
"code": "D007603",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.706.535"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Capacité mentale",
"alternateName": "Mental Competency",
"code": {
"@type": "MedicalCode",
"code": "D016743",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jane Meschan Foy",
"url": "https://questionsmedicales.fr/author/Jane%20Meschan%20Foy",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, School of Medicine, Wake Forest University, Winston-Salem, North Carolina; foy.jane@gmail.com."
}
},
{
"@type": "Person",
"name": "Cori M Green",
"url": "https://questionsmedicales.fr/author/Cori%20M%20Green",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Weill Cornell Medicine, Cornell University, New York, New York; and."
}
},
{
"@type": "Person",
"name": "Marian F Earls",
"url": "https://questionsmedicales.fr/author/Marian%20F%20Earls",
"affiliation": {
"@type": "Organization",
"name": "Community Care of North Carolina, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Cori Green",
"url": "https://questionsmedicales.fr/author/Cori%20Green",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Weill Cornell Medicine, New York, New York; cmg9004@med.cornell.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37318715",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40199-023-00465-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring.",
"datePublished": "2022-10-06",
"url": "https://questionsmedicales.fr/article/36271558",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2022.113777"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smart Multiplex Point-of-Care Platform for Simultaneous Drug Monitoring.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37499237",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsami.3c06461"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the Key.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36982592",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24065518"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.",
"datePublished": "2022-06-13",
"url": "https://questionsmedicales.fr/article/35588142",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcph.2068"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Contrôle social formel",
"item": "https://questionsmedicales.fr/mesh/D012926"
},
{
"@type": "ListItem",
"position": 4,
"name": "Jurisprudence",
"item": "https://questionsmedicales.fr/mesh/D007603"
},
{
"@type": "ListItem",
"position": 5,
"name": "Capacité mentale",
"item": "https://questionsmedicales.fr/mesh/D016743"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Capacité mentale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Capacité mentale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Capacité mentale",
"description": "Comment évaluer la capacité mentale d'un patient ?\nQuels signes indiquent une altération de la capacité mentale ?\nQuels professionnels évaluent la capacité mentale ?\nQuelles échelles sont utilisées pour le diagnostic ?\nQuand consulter un spécialiste pour un diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Drug+Monitoring&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Capacité mentale",
"description": "Quels sont les symptômes d'une capacité mentale altérée ?\nLa dépression affecte-t-elle la capacité mentale ?\nComment le stress impacte-t-il la capacité mentale ?\nLes troubles du sommeil influencent-ils la capacité mentale ?\nQuels changements de comportement signalent une altération ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Drug+Monitoring&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Capacité mentale",
"description": "Comment prévenir l'altération de la capacité mentale ?\nL'alimentation influence-t-elle la capacité mentale ?\nLe contrôle du stress est-il important ?\nLes activités mentales préventives sont-elles efficaces ?\nLe suivi médical régulier est-il nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Drug+Monitoring&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Capacité mentale",
"description": "Quels traitements existent pour améliorer la capacité mentale ?\nLa rééducation cognitive est-elle efficace ?\nQuels médicaments peuvent aider à la capacité mentale ?\nLa thérapie de groupe est-elle bénéfique ?\nLes exercices physiques aident-ils la capacité mentale ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Drug+Monitoring&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Capacité mentale",
"description": "Quelles complications peuvent résulter d'une capacité mentale altérée ?\nL'isolement social est-il une complication fréquente ?\nLes accidents sont-ils plus fréquents chez ces patients ?\nComment la capacité mentale altérée affecte-t-elle les relations ?\nLes troubles mentaux peuvent-ils aggraver d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Drug+Monitoring&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Capacité mentale",
"description": "Quels sont les facteurs de risque pour une altération de la capacité mentale ?\nLe tabagisme influence-t-il la capacité mentale ?\nLe manque d'activité physique est-il un facteur de risque ?\nLes traumatismes crâniens augmentent-ils le risque ?\nLes troubles de l'humeur sont-ils des facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D016743?mesh_terms=Drug+Monitoring&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la capacité mentale d'un patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des tests psychométriques et des entretiens cliniques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une altération de la capacité mentale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Confusion, désorientation, incapacité à prendre des décisions éclairées."
}
},
{
"@type": "Question",
"name": "Quels professionnels évaluent la capacité mentale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Psychologues, psychiatres et médecins généralistes sont impliqués dans l'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles échelles sont utilisées pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échelle de Mini-Mental State Examination (MMSE) est couramment utilisée."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste pour un diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si des changements de comportement ou de cognition sont observés, consultez un spécialiste."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une capacité mentale altérée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Difficultés de concentration, mémoire défaillante, jugement altéré."
}
},
{
"@type": "Question",
"name": "La dépression affecte-t-elle la capacité mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dépression peut altérer la concentration et le jugement, affectant la capacité mentale."
}
},
{
"@type": "Question",
"name": "Comment le stress impacte-t-il la capacité mentale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut entraîner des troubles de la concentration et de la mémoire."
}
},
{
"@type": "Question",
"name": "Les troubles du sommeil influencent-ils la capacité mentale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un sommeil insuffisant peut nuire à la mémoire et à la prise de décision."
}
},
{
"@type": "Question",
"name": "Quels changements de comportement signalent une altération ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Isolement social, irritabilité, et changements d'humeur fréquents peuvent être des signes."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'altération de la capacité mentale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une vie active, équilibrée et socialement engagée aide à prévenir les troubles."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la capacité mentale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en oméga-3 et antioxydants favorise la santé cognitive."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de gestion du stress comme la méditation peuvent aider à préserver la cognition."
}
},
{
"@type": "Question",
"name": "Les activités mentales préventives sont-elles efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeux de réflexion et la lecture stimulent le cerveau et peuvent retarder le déclin."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier est-il nécessaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers permettent de détecter précocement des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour améliorer la capacité mentale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie cognitive, la médication et les exercices mentaux."
}
},
{
"@type": "Question",
"name": "La rééducation cognitive est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à restaurer certaines fonctions cognitives et à améliorer la prise de décision."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aider à la capacité mentale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs de la cholinestérase sont souvent prescrits pour les troubles cognitifs."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle bénéfique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle favorise le soutien social et peut améliorer la cognition par l'interaction."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils la capacité mentale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé cognitive."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une capacité mentale altérée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'incapacité à gérer les finances et les soins personnels."
}
},
{
"@type": "Question",
"name": "L'isolement social est-il une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec une capacité mentale altérée peuvent s'isoler, aggravant leur état."
}
},
{
"@type": "Question",
"name": "Les accidents sont-ils plus fréquents chez ces patients ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une altération de la capacité mentale augmente le risque d'accidents domestiques."
}
},
{
"@type": "Question",
"name": "Comment la capacité mentale altérée affecte-t-elle les relations ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des conflits familiaux et des difficultés de communication."
}
},
{
"@type": "Question",
"name": "Les troubles mentaux peuvent-ils aggraver d'autres maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité mentale altérée peut aggraver des maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour une altération de la capacité mentale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les antécédents familiaux et les maladies chroniques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la capacité mentale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un déclin cognitif accru et à des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Le manque d'activité physique est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inactivité physique est liée à un risque accru de déclin cognitif."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes crâniens peuvent entraîner des troubles cognitifs à long terme."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils des facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de l'humeur comme la dépression augmentent le risque de déclin cognitif."
}
}
]
}
]
}
Chronic oral anticancer therapies, are increasingly prescribed and present new challenges including the enhanced risk of overlooked drug-drug interactions (DDIs). Lengthy treatments and patients' mana...
This report aims to exemplify how an intensified pharmacological approach could help in the clinical monitoring of patients on chronic treatments....
A patient with gastrointestinal stromal tumor was referred to our clinical pharmacology service due to tumor progression while on imatinib therapy. The investigation was based on TDM, pharmacogenetics...
TDM analysis revealed that the patient was underexposed to imatinib (C...
The active pharmacological monitoring allowed the identification of a dangerous previously over-looked DDI leading to IMA under-exposure. The switch to a different antiepileptic treatment, reversed th...
The revised vancomycin guidelines recommend replacing trough-only with trough or peak/trough Bayesian and first-order equations monitoring, citing their better AUC predictions and poor AUC-trough R...
The primary aim is to compare the predictive performance of the AUC monitoring methods. Then, we investigate the impact of not adhering to trough sampling on the Bayesian-based predictions. Moreover, ...
We calculated the predictive performance of the monitoring methods using a standard PopPK modeling and simulation approach. We thoroughly explored the prior PK models implemented in Bayesian programs....
Predictive performances of the monitoring methods were comparable at steady-state relative to the number of samples. Contrary to the recommendation, Bayesian trough monitoring did not result in better...
All the monitoring methods can be, relatively, reliable at steady-state, if properly implemented. Although only Bayesian-based monitoring can be used pre-steady-state, its predictive performance can b...
Recently, illicit drug use has become more widespread and is linked to problems with crime and public health. These drugs disrupt consciousness, affecting perceptions and feelings. Combining stimulant...
A combination of tyrosine kinase inhibitors (TKIs) is likely to be a therapeutic option for numerous oncological situations due to high frequency of oncogenic addiction and progress in precision oncol...
Patients with tuberculosis (TB) coinfected with HIV are more likely to have low blood concentrations of the first-line anti-TB drugs (associated with poor outcomes). Therapeutic drug monitoring (TDM) ...
In this report, two cases of patients with severe adverse events after an adjuvant treatment with capecitabine are described in detail. The first patient suffered from a severe ileocolitis, where ulti...
Data evaluating cefepime thresholds associated with neurotoxicity remain limited. The objectives of this study were to evaluate the incidence of cefepime-related neurotoxicity (CRN) in patients with p...
This was a retrospective study of adult inpatients admitted between 2016 and 2018 who received cefepime therapeutic drug monitoring (TDM). Potential CRN cases were identified utilizing a standard defi...
Four hundred eighty-one patients with 503 hospital encounters received cefepime TDM and were included in the analysis. The incidence of CRN was 4.4% (22/503). Patients with CRN had a higher incidence ...
Cefepime should be used cautiously in hospitalized patients with renal dysfunction due to the risk of neurotoxicity. Dose optimization utilizing TDM early in cefepime treatment may minimize adverse ef...
Treatment of infective endocarditis (IE) is based on high doses of antibiotics with a prolonged duration. Therapeutic drug monitoring (TDM) allows antibiotic prescription optimization and leads to a p...
Therapeutic drug monitoring (TDM) is performed for drugs with narrow therapeutic indices. At Seoul National University Hospital (SNUH) and Seoul National University Bundang Hospital (SNUBH), TDM servi...
This review describes current knowledge of ganciclovir (GCV) and valganciclovir (ValGCV) pharmacokinetic/pharmacodynamic characteristics, highlighting the likely contribution from host genetic factors...
Pharmacokinetic studies of current dosing guidelines have shown high interindividual and intraindividual variability of GCV concentrations. This is sometimes associated with a slow decline in cytomega...
Further studies examining novel biomarkers are needed to guide target concentrations in prophylaxis and treatment. The use of TDM in transplant recipients is likely to improve the clinical efficacy of...